Literature DB >> 21220015

Update on the pathology of dystonia.

David G Standaert1.   

Abstract

Dystonia is a clinical syndrome with sustained muscle contraction, twisting, and abnormal postures. A number of different genetic forms have been defined, but most cases are sporadic in nature and of uncertain cause. Relatively few cases of dystonia have been studied pathologically. In primary dystonias, where dystonia is the main symptom, most reports describe little or no detectable neuropathology, although changes in brainstem neurons have been described in some cases. Secondary dystonias are associated with degenerative or destructive diseases of the nervous system; the pathology may be located in the basal ganglia, but in some cases the primary pathological changes are found in the cerebellum or cerebellar outflow pathways, suggesting that both regions may be involved in the pathogenesis of dystonic symptoms. Overall the number of well-documented pathological cases available for study is few, and there is an urgent need for additional postmortem studies. This article is part of a Special Issue entitled "Advances in dystonia".
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21220015      PMCID: PMC3073692          DOI: 10.1016/j.nbd.2011.01.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  48 in total

Review 1.  Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Authors:  J Rivest; N Quinn; C D Marsden
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

Review 2.  The dystonias.

Authors:  C D Marsden; N P Quinn
Journal:  BMJ       Date:  1990-01-20

3.  Striatal degeneration in glutaric acidaemia type II.

Authors:  C W Chow; F E Frerman; S I Goodman; G K Brown; J J Pitt; D M Danks
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Progressive dystonia following resuscitation from cardiac arrest.

Authors:  K B Boylan; J H Chin; S J DeArmond
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

5.  Meige syndrome in the spectrum of Lewy body disease.

Authors:  M H Mark; J I Sage; D W Dickson; R E Heikkila; L Manzino; K O Schwarz; R C Duvoisin
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

6.  Cervical dystonia associated with tumors of the posterior fossa.

Authors:  J K Krauss; W Seeger; J Jankovic
Journal:  Mov Disord       Date:  1997-05       Impact factor: 10.338

7.  Novel THAP1 sequence variants in primary dystonia.

Authors:  J Xiao; Y Zhao; R W Bastian; J S Perlmutter; B A Racette; S D Tabbal; M Karimi; R C Paniello; Z K Wszolek; R J Uitti; J A Van Gerpen; D K Simon; D Tarsy; P Hedera; D D Truong; K P Frei; S Dev Batish; A Blitzer; R F Pfeiffer; S Gong; M S LeDoux
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

Review 8.  The pathophysiological basis of dystonias.

Authors:  Xandra O Breakefield; Anne J Blood; Yuqing Li; Mark Hallett; Phyllis I Hanson; David G Standaert
Journal:  Nat Rev Neurosci       Date:  2008-03       Impact factor: 34.870

9.  Cerebellothalamocortical connectivity regulates penetrance in dystonia.

Authors:  Miklos Argyelan; Maren Carbon; Martin Niethammer; Aziz M Ulug; Henning U Voss; Susan B Bressman; Vijay Dhawan; David Eidelberg
Journal:  J Neurosci       Date:  2009-08-05       Impact factor: 6.167

10.  Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study.

Authors:  Susan B Bressman; Deborah Raymond; Tania Fuchs; Gary A Heiman; Laurie J Ozelius; Rachel Saunders-Pullman
Journal:  Lancet Neurol       Date:  2009-04-01       Impact factor: 44.182

View more
  50 in total

1.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

3.  Dimerization of the DYT6 dystonia protein, THAP1, requires residues within the coiled-coil domain.

Authors:  Cem Sengel; Sophie Gavarini; Nutan Sharma; Laurie J Ozelius; D Cristopher Bragg
Journal:  J Neurochem       Date:  2011-08-08       Impact factor: 5.372

Review 4.  Hyperkinetic disorders and loss of synaptic downscaling.

Authors:  Paolo Calabresi; Antonio Pisani; John Rothwell; Veronica Ghiglieri; Josè A Obeso; Barbara Picconi
Journal:  Nat Neurosci       Date:  2016-06-28       Impact factor: 24.884

5.  Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a.

Authors:  Sara B Mitchell; Sadahiro Iwabuchi; Hiroyuki Kawano; Tsun Ming Tom Yuen; Jin-Young Koh; K W David Ho; N Charles Harata
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

6.  Negative dystonia of the palate: a novel entity and diagnostic consideration in hypernasal speech.

Authors:  Catherine F Sinclair; Kristina Simonyan; Mitchell F Brin; Andrew Blitzer
Journal:  Laryngoscope       Date:  2015-02-03       Impact factor: 3.325

7.  Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia.

Authors:  Chang-Hyun Song; Doug Bernhard; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2013-10-11       Impact factor: 5.996

8.  SCA 6 with Writer's Cramp: The Phenotype Expanded.

Authors:  Diana Angelika Olszewska; Richard Walsh; Tim Lynch
Journal:  Mov Disord Clin Pract       Date:  2015-08-26

Review 9.  Alternative approaches to modeling hereditary dystonias.

Authors:  Rachel Fremont; Kamran Khodakhah
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

10.  TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration.

Authors:  Chun-Chi Liang; Lauren M Tanabe; Stephanie Jou; Frank Chi; William T Dauer
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.